Predictors of secukinumab treatment response and continuation in axial spondyloarthritis
Marion Pons, Stylianos Georgiadis, Merete Lund Hetland, Z. Faizy Ahmadzay et autres
0 citationsDiRROS repository (University of Maribor)
Z. Faizy Ahmadzay
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
12Publications signalées
10Citations signalées
4Affiliations récentes
Institutions déclarées
Domaines associés
Spondyloarthritis Studies and TreatmentsRheumatoid Arthritis Research and TherapiesPsoriasis: Treatment and PathogenesisAutoimmune and Inflammatory Disorders ResearchMacrophage Migration Inhibitory Factor
Publications récentes
Impact of cardiometabolic comorbidities on clinical characteristics, prescription patterns and retention rate of first b/tsDMARD treatment in 5299 European real-world patients with psoriatic arthritis
Z. Faizy Ahmadzay, Lykke Midtbøll Ørnbjerg, Mikkel Østergaard, Kasper Yde Jensen et autres
0 citationsRMD Open
The impact of smoking and obesity on secukinumab effectiveness in psoriatic arthritis: real-world evidence from 1202 European patients.
Z. Faizy Ahmadzay, Stylianos Georgiadis, Mikkel Østergaard, Bente Glintborg et autres
0 citationsOpen Access CRIS of the University of Bern
The impact of smoking and obesity on secukinumab effectiveness in psoriatic arthritis: real-world evidence from 1202 European patients
Z. Faizy Ahmadzay, Stylianos Georgiadis, Mikkel Østergaard, Bente Glintborg et autres
0 citationsEULAR Rheumatology Open
Impact of cardiometabolic comorbidities on clinical characteristics, prescription patterns and retention rate of first b/tsDMARD treatment in 5299 European real-world patients with psoriatic arthritis.
Z. Faizy Ahmadzay, Lykke Midtbøll Ørnbjerg, Mikkel Østergaard, Kasper Yde Jensen et autres
0 citationsOpen Access CRIS of the University of Bern
POS1250 ASSOCIATION BETWEEN METABOLIC COMORBIDITIES AND RETENTION RATES OF FIRST-LINE b/tsDMARD TREATMENT IN PATIENTS WITH PSORIATIC ARTHRITIS: EUROPEAN REAL-WORLD RESULTS
Z. Faizy Ahmadzay, Lykke Midtbøll Ørnbjerg, M. Østergaard, J. Jørgensen et autres
0 citationsAnnals of the Rheumatic Diseases
ABS1150 SEX-BASED DIFFERENCES IN PREDICTORS OF SECUKINUMAB EFFECTIVENESS IN EUROPEAN ROUTINE CARE PATIENTS WITH PSORIATIC ARTHRITIS: RESULTS FROM THE EuroSpA COLLABORATION
J. Heberg, Stylianos Georgiadis, Z. Faizy Ahmadzay, Bente Glintborg et autres
0 citationsAnnals of the Rheumatic Diseases
Predictors of Secukinumab Treatment Response and Continuation in Axial Spondyloarthritis: Results From the EuroSpA Research Collaboration Network
Marion Pons, Stylianos Georgiadis, Merete Lund Hetland, Z. Faizy Ahmadzay et autres
4 citationsThe Journal of Rheumatology
Four-year secukinumab treatment outcomes in European real-world patients with axial spondyloarthritis and psoriatic arthritis
Marion Pons, Stylianos Georgiadis, Mikkel Østergaard, Z. Faizy Ahmadzay et autres
6 citationsJoint Bone Spine
OP0183 PREDICTORS OF SECUKINUMAB TREATMENT RESPONSE AND CONTINUATION IN AXIAL SPONDYLOARTHRITIS: RESULTS FROM THE EUROSPA RESEARCH COLLABORATION NETWORK
Stylianos Georgiadis, M. Østergaard, Z. Faizy Ahmadzay, S. Horskjær Rasmussen et autres
0 citationsAnnals of the Rheumatic Diseases
POS0954 THE IMPACT OF SMOKING STATUS ON ONE-YEAR SECUKINUMAB RETENTION RATE IN 1,684 PATIENTS WITH PSORIATIC ARTHRITIS: REAL-WORLD RESULTS FROM THE EUROSPA COLLABORATION
Z. Faizy Ahmadzay, Stylianos Georgiadis, Miquel Pons, Merete Lund Hetland et autres
0 citationsAnnals of the Rheumatic Diseases
Predictors of Secukinumab Treatment Response and Continuation in Axial Spondyloarthritis: Results from the Eurospa Research Collaboration Network
Lykke Midtbøll Ørnbjerg, Marion Pons, Stylianos Georgiadis, Merete Lund Hetland et autres
0 citationsSSRN Electronic Journal
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.